These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28249042)

  • 1. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
    Cai F; Xiao X; Niu X; Zhong Y
    PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies.
    Shi H; Chen X; Lu C; Gu C; Jiang H; Meng R; Niu X; Huang Y; Lu M
    PLoS One; 2015; 10(4):e0122302. PubMed ID: 25835498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.
    Jia W; Yu T; Cao X; An Q; Yang H
    Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
    Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C
    PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
    Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
    Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.
    Li Y; Zhu M; Zhang X; Cheng D; Ma X
    Drug Des Devel Ther; 2015; 9():1785-96. PubMed ID: 25848215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
    Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
    Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
    Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
    Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
    Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
    PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.
    Yang XY; Zhang J; Yu XL; Zheng GF; Zhao F; Jia XJ
    J Cancer Res Ther; 2018; 14(Supplement):S65-S71. PubMed ID: 29578152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis.
    Meng RW; Li YC; Chen X; Huang YX; Shi H; Du DD; Niu X; Lu C; Lu MX
    Sci Rep; 2016 Feb; 6():20756. PubMed ID: 26857374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients.
    Laytragoon-Lewin N; Chen F; Castro J; Elmberger G; Rutqvist LE; Lewin F; Turesson I; Lundgren J
    Anticancer Res; 2010 Nov; 30(11):4643-8. PubMed ID: 21115918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis.
    Wang H; Zhou LY; Guan ZB; Zeng WB; Zhou LL; Liu YN; Pan XY
    PLoS One; 2019; 14(1):e0210943. PubMed ID: 30682070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Don KR; Ramani P; Ramshankar V; Sherlin HJ; Premkumar P; Natesan A
    Indian J Dent Res; 2014; 25(6):797-805. PubMed ID: 25728117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis.
    Cai F; Xiao X; Niu X; Shi H; Zhong Y
    PLoS One; 2016; 11(9):e0163534. PubMed ID: 27657735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients.
    Liu Y; Zhou ZT; He QB; Jiang WW
    Med Oncol; 2012 Jun; 29(2):729-33. PubMed ID: 21516484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.
    Qi M; Xiong X
    Medicine (Baltimore); 2018 Dec; 97(51):e13666. PubMed ID: 30572486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.